Study guide
15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications
NCCAOM Acupuncture and Oriental Medicine Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Preparation Strategy
1.1 NCBAHM Certification Pathways & Exam Logistics 1.2 Study Strategies & Computer Adaptive Testing (CAT) Mechanics 1.3 Clean Needle Technique (CNT) & Safety Prerequisite Fundamentals
2 Chapter 2: Fundamental Theories of Oriental Medicine
2.1 Yin-Yang Theory and Clinical Applications 2.2 Five Elements / Five Phases (Wu Xing) 2.3 Vital Substances: Qi, Blood, Body Fluids, Jing, and Shen 2.4 Etiology and Pathogenesis: Six Evils, Seven Emotions, and Miscellaneous Causes
3 Chapter 3: Zang-Fu Organ Physiology and Pathologies
3.1 Zang Organ Patterns I: Heart and Lung 3.2 Zang Organ Patterns II: Spleen, Liver, and Kidney 3.3 Fu (Yang) Organ Physiology and Patterns 3.4 Complex and Combined Zang-Fu Disharmonies 3.5 Extraordinary Fu Organs and Clinical Applications
4 Chapter 4: The Four Examinations and Diagnostic Methods
4.1 Observation (Wang Zhen): Spirit, Complexion, Body, and Excretions 4.2 Tongue Diagnosis (She Zhen): Body, Coating, and Sublingual Veins 4.3 Auscultation and Olfaction (Wen Zhen) 4.4 Inquiry I: The Ten Questions, Fever and Chills, Sweating, and Pain 4.5 Inquiry II: Digestion, Excretion, Sleep, Senses, Gynecology, and History 4.6 Palpation (Qie Zhen): Comprehensive 28 Pulses, Channels, and Abdominal Zones
5 Chapter 5: Pattern Differentiation Frameworks & Treatment Principles
5.1 Eight Principles (Ba Gang) Differentiation 5.2 Six Stages (Liu Jing) Differentiation 5.3 Four Levels (Wei-Qi-Ying-Xue) Differentiation of Warm Disease 5.4 San Jiao (Triple Burner) Differentiation 5.5 Channel (Jing Luo) Differentiation: Primary Channels, Luo Vessels, and Channel Sinews 5.6 Treatment Principles and Formulating Therapeutic Strategies 5.7 Treatment Planning in Practice: Priorities, Plan Changes, Patient Education, and Self-Care 5.8 Chinese Dietary Therapy: Temperature, Flavor, and Function
6 Chapter 6: Channel Systems and Point Location Methodology
6.1 Anatomical Landmarks and Proportional Cun Measurements 6.2 The Twelve Primary Channels: Trajectories and Internal Pathways 6.3 Eight Extraordinary Vessels (Qi Jing Ba Mai)
7 Chapter 7: Channel Points I: Taiyin, Yangming, Shaoyin, and Taiyang
7.1 Taiyin Channels: Lung (LU) and Spleen (SP) Points 7.2 Yangming Channels: Large Intestine (LI) and Stomach (ST) Points 7.3 Shaoyin Channels: Heart (HT) and Kidney (KI) Points 7.4 Taiyang Channels: Small Intestine (SI) and Urinary Bladder (BL) Points
8 Chapter 8: Channel Points II: Jueyin, Shaoyang, Du, Ren, and Extra Points
8.1 Jueyin Channels: Pericardium (PC) and Liver (LR) Points 8.2 Shaoyang Channels: San Jiao (SJ) and Gallbladder (GB) Points 8.3 Du Mai (Governing Vessel) and Ren Mai (Conception Vessel) Points 8.4 Essential Extra Points (Non-Channel Points)
9 Chapter 9: Specific Point Categories and Prescription Theory
9.1 Five Shu Points and Five-Element Dynamics 9.2 Source (Yuan), Connecting (Luo), and Cleft (Xi) Points 9.3 Back-Shu, Front-Mu, and Lower He-Sea Points 9.4 Eight Confluent, Influential (Hui), and Special Category Points
10 Chapter 10: Point Selection Strategies and Treatment Planning
10.1 Point Selection Strategies: Local, Adjacent, Distal, Theory-Based, and Mirroring 10.2 Auriculotherapy: Ear Anatomy, Point Map, Protocols, and Ear Seeds 10.3 Scalp Acupuncture: Systems, Stimulation Areas, Technique, and Indications 10.4 Myofascial Trigger Points, Motor Points, and Dry Needling Techniques 10.5 Designing the Treatment Plan: Methods, Frequency, Expectations, and Progress Evaluation 10.6 Adjusting Treatment for Special Populations: Children, Older Adults, Pregnancy, Disabilities, and Trauma History 10.7 Pattern-Based Prescriptions I: Pain, Bi Syndrome, Headache, and Musculoskeletal Conditions 10.8 Pattern-Based Prescriptions II: Internal, Gynecological, and Emotional Conditions
11 Chapter 11: Needling Techniques, Safety, Contraindications & Adjunctive Therapies
11.1 Needle Insertion, Angles, Depths, and De Qi Manipulation 11.2 Patient Positioning, Draping, Needle Selection, Retention, and Removal 11.3 Acupuncture Safety, Anatomical Hazards, and Complications Management 11.4 Contraindications and Special Patient Populations 11.5 Moxibustion: Mediums, Methods, and Safety 11.6 Cupping, Gua Sha, and Bloodletting 11.7 Electroacupuncture, Heat Lamps, Tuina, and Acupressure
12 Chapter 12: Biomedical Sciences, Clinical Anatomy, and Medical Conditions
12.1 Cardiovascular Conditions: Anatomy, Coronary Disease, Heart Failure, and Blood Pressure 12.2 Pulmonary Conditions: Asthma, COPD, Pneumonia, Pulmonary Embolism, and Pneumothorax 12.3 Gastrointestinal and Hepatobiliary Conditions 12.4 Renal, Urinary, Endocrine, and Metabolic Conditions 12.5 Neuromusculoskeletal Anatomy, Dermatomes, and Neuropathies 12.6 Neurological Conditions: Headache, Neuralgia, Vertigo, Seizures, Dementia, and Neurodegenerative Disease 12.7 Musculoskeletal, Autoimmune, and Genetic Conditions 12.8 Reproductive Conditions: Menstrual Disorders, Infertility, Pregnancy, Menopause, Breast, and Prostate 12.9 Mental, Neurodevelopmental, Behavioral, and Substance Use Conditions 12.10 Infectious and Dermatological Conditions 12.11 Hematologic, Oncologic, Eye and ENT, and Multi-System Conditions
13 Chapter 13: Patient Evaluation, Physical Examination & Diagnostic Tests
13.1 Patient History, Vital Signs, and Systemic Review 13.2 Neurological Examination: Cranial Nerves, Motor, Sensory, and Reflexes 13.3 Orthopedic Examination: Range of Motion, Strength, and Special Tests 13.4 Diagnostic Medical Imaging Indications and Interpretation 13.5 Clinical Laboratory Interpretation (Blood, Urine, Metabolic Panels) 13.6 Other Diagnostic Tests, Endoscopy, and Preventive Screening
14 Chapter 14: Clinical Decision-Making, Red Flags & Medical Referrals
14.1 Red Flag Identification and Clinical Triage Categories 14.2 Neurological and Cardiovascular Emergencies 14.3 Oncologic, Surgical, and Infectious Red Flags 14.4 Case Management, Medical Necessity, Social Determinants of Health, and Evidence-Based Practice 14.5 Interprofessional Communication and Referral Documentation
15 Chapter 15: Pharmacology, Supplements, and Interactions
15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications 15.2 Pharmacology II: Endocrine, Psychiatric, Neurological, Anti-infective, Respiratory, GI, and Other Drug Classes 15.3 Dietary Supplements: Vitamins, Minerals, Amino Acids, Herbal, Homeopathic, and Hormonal Products 15.4 Drug-Herb and Drug-Nutrient Interactions
16 Chapter 16: Professional Responsibilities, Infection Control, and Emergency Management
16.1 Legal Regulations, HIPAA, Informed Consent, and Scope of Practice 16.2 Professional Ethics: The NCBAHM Code of Ethics, Grounds for Discipline, Boundaries, and Federal Laws 16.3 Records Management, Professional Insurance, and ICD and CPT Coding 16.4 Infection Control, Biohazard Management, and OSHA/CDC Compliance 16.5 Emergency Management in the Clinic: CPR and AED, Choking, Anaphylaxis, Hypoglycemia, Seizures, and Falls
15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications
Key Takeaways Explain This Topic AI
Cardiovascular pharmaceuticals alter autonomic, hemodynamic, and fluid baselines: ACE inhibitors induce persistent dry hacking cough via bradykinin accumulation; Beta-blockers cause resting bradycardia and mask hypoglycemic sympathetic warning signs in diabetics; Calcium Channel Blockers induce dependent peripheral ankle edema; Diuretics cause profound electrolyte disturbances, hypokalemia, and hyperuricemia triggering gout.
Anticoagulant and antiplatelet agents (Warfarin with target INR 2.0–3.0, DOACs like apixaban and rivaroxaban, and antiplatelets like aspirin and clopidogrel) drastically elevate hemorrhagic and hematoma risks, mandating strict acupuncture modifications: avoiding deep intramuscular needling, vigorous needle manipulation, and contraindicating cupping, gua sha, and bleeding techniques.
Statins (HMG-CoA reductase inhibitors) frequently present as clinical masqueraders of musculoskeletal complaints: statin-induced myopathy and life-threatening rhabdomyolysis manifest with bilateral proximal muscle weakness, aching, myoglobinuria (tea-colored urine), and elevated serum creatine kinase (CK), requiring immediate medical referral rather than treatment for myofascial pain or Qi stagnation.
NSAIDs cause stomach bleeding and kidney injury, acetaminophen damages the liver above the 4,000 mg daily maximum (lower with heavy alcohol use), and long-term corticosteroids cause osteoporosis and fragile skin.
Last updated: October 2026
15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications
Quick Answer: Modern acupuncture practice requires fluency in biomedical pharmacology to prevent adverse events, recognize drug-induced clinical mimics, and modify needling safely. Cardiovascular drugs present specific challenges: ACE inhibitors (lisinopril) cause a dry, non-productive hacking cough (bradykinin accumulation) and angioedema; Beta-blockers (metoprolol) cause bradycardia and blunt adrenergic hypoglycemic warning signs (tachycardia, tremor) in diabetics; Calcium Channel Blockers (amlodipine) cause dependent bilateral ankle edema and gingival hyperplasia; Diuretics (furosemide, hydrochlorothiazide) cause hypokalemia, dehydration, and hyperuricemic gout flares. Anticoagulants (Warfarin, target INR 2.0–3.0; DOACs like apixaban/Eliquis and rivaroxaban/Xarelto) and Antiplatelets (aspirin, clopidogrel) cause severe hematoma risks, requiring fine-gauge needles, gentle insertion, prolonged direct pressure, and absolute contraindication of wet cupping and vigorous gua sha. Statins (atorvastatin) induce myopathy and rhabdomyolysis presenting as bilateral proximal muscle pain and tea-colored urine with elevated creatine kinase. Endocrine, psychiatric, anti-infective, and other drug classes on the outline are covered in Section 15.2.
The Clinical Intersection of Pharmacology and East Asian Medicine
In modern integrative clinical practice, an acupuncturist frequently evaluates patients receiving multi-drug regimens for complex chronic diseases. Pharmaceutical agents alter baseline physiology, modify autonomic tone, suppress immune responses, and alter vascular integrity. Board examinations regularly evaluate an examinee's ability to identify adverse drug effects, distinguish drug toxicities from primary East Asian pattern disharmonies, and apply appropriate safety protocols. +----------------------------------------------------------------------------+
- | PHARMACOLOGICAL SAFETY SCREENING ARCHITECTURE |
- +----------------------------------------------------------------------------+
- | [Cardiovascular Agents] --> Hypotension, bradycardia, bleeding, edema |
- | [Anticoagulants / DOACs] --> Severe hematoma, microtrauma, INR checks |
- | [Lipid-Lowering Statins] --> Statin myopathy vs. myofascial pain mimic |
- | [Analgesics / NSAIDs] --> GI bleeding, masked inflammation, renal fail|
- | [Corticosteroids] --> Osteoporosis, skin fragility, HPA collapse |
- | [Endocrine / Diabetic] --> Hypoglycemia, lactic acidosis, euglycemic DKA|
- | [Psychiatric / SSRIs] --> Serotonin syndrome, sedation, withdrawal |
- | [Fluoroquinolones] --> Black box warning for Achilles tendon rupture|
- +----------------------------------------------------------------------------+
- Cardiovascular Medications
Cardiovascular drugs represent the most commonly prescribed pharmaceutical class in outpatient adult populations. These agents directly alter blood pressure, cardiac output, vascular tone, fluid volume, and coagulation pathways.
Drug Subclass Representative Agents Biochemical Mechanism Classic Adverse Side Effects Acupuncture & Clinical Safety Implications
ACE Inhibitors Lisinopril, Enalapril, Ramipril, Benazepril Inhibit Angiotensin-Converting Enzyme, blocking conversion of Angiotensin I to Angiotensin II; prevents degradation of bradykinin Chronic dry hacking cough (10–20%), angioedema (life-threatening airway compromise), hyperkalemia, hypotension, dizziness Do not misdiagnose drug cough as Lung Yin deficiency or Wind-Heat invasion; refer for ARB substitution if cough is intolerable; monitor orthostatic vitals
Angiotensin Receptor Blockers (ARBs) Losartan, Valsartan, Olmesartan, Irbesartan Selectively block Angiotensin II Type 1 (AT1) receptors; no effect on bradykinin breakdown Hyperkalemia, dizziness, hypotension, renal impairment Safer alternative for patients with ACE-inhibitor cough; check for orthostasis prior to treatment
Beta-Adrenergic Blockers Metoprolol, Atenolol, Propranolol, Carvedilol Competitively antagonize beta-1 (and beta-2) adrenergic receptors; decrease heart rate, inotropy, and cardiac output; suppress renin release Bradycardia (<60 bpm), fatigue, exercise intolerance, bronchospasm (in asthmatics), cold extremities, erectile dysfunction Blunts adrenergic warning signs of hypoglycemia (tachycardia, tremors) in diabetics; diaphoresis remains intact; check resting pulse before needling
Calcium Channel Blockers (CCBs) Amlodipine, Nifedipine (dihydropyridines); Diltiazem, Verapamil (non-dihydropyridines) Inhibit L-type voltage-gated calcium channels in vascular smooth muscle (vasodilation) and myocardium Dependent bilateral pedal/ankle edema (dihydropyridines), gingival hyperplasia, bradycardia (non-dihydropyridines), severe constipation (verapamil) Do not confuse CCB-induced ankle edema with congestive heart failure, renal failure, or Spleen/Kidney Yang deficiency edema; caution with electrical stimulation
Thiazide Diuretics Hydrochlorothiazide (HCTZ), Chlorthalidone Inhibit Na+/Cl- cotransporter in the renal distal convoluted tubule; promote natriuresis and mild diuresis Hypokalemia , hyponatremia, hyperuricemia (gout precipitation) , hyperglycemia, dehydration, orthostatic hypotension Monitor for muscle cramps, arrhythmias; examine hot swollen 1st MTP joints for acute gout triggered by HCTZ; ensure hydration
Loop Diuretics Furosemide (Lasix), Bumetanide, Torsemide Inhibit Na+/K+/2Cl- symporter in the thick ascending limb of the loop of Henle; profound natriuresis and diuresis Severe hypokalemia , hypomagnesemia, hypocalcemia, dehydration, ototoxicity, orthostatic syncope High risk of vasovagal needle shock if hypovolemic; monitor electrolytes; profound hypokalemia sensitizes myocardium to arrhythmias
In-Depth Antihypertensive Clinical Dynamics
ACE Inhibitor Cough vs. Lung Disharmony : Up to 20% of patients receiving lisinopril or enalapril develop a persistent, dry, non-productive, hacking nocturnal cough. The mechanism is pharmacological: ACE is identical to kininase II, the pulmonary enzyme responsible for degrading bradykinin and substance P. When ACE is blocked, bradykinin accumulates in the bronchial mucosa, stimulating sensory C-fibers and provoking bronchoconstriction and dry cough. In an acupuncture clinic, this presentation is frequently misattributed to Lung Yin Deficiency or Wind-Dryness attacking the Lung . Acupuncturists must cross-reference medication lists; the cough is completely refractory to antitussive herbs and resolves only when the patient's physician substitutes an ARB (e.g., losartan).
Beta-Blocker Blunting of Hypoglycemia : In healthy individuals, an acute drop in blood glucose triggers a robust sympathoadrenal discharge of epinephrine and norepinephrine. This catecholamine surge generates classic neurogenic warning symptoms: palpitations, sinus tachycardia, anxiety, and fine muscle tremors. In a diabetic patient taking a beta-blocker (such as metoprolol or atenolol), beta-1 and beta-2 blockade extinguishes these cardiac and motor warning signs. The patient may slide precipitously into neuroglycopenia, cognitive confusion, seizures, or coma without noticing tachycardia. Crucially, diaphoresis (profuse sweating) is mediated by sympathetic cholinergic postganglionic muscarinic pathways and is not blunted by beta-blockers. Diaphoresis is therefore the primary remaining somatic indicator of acute hypoglycemia in these patients.
Calcium Channel Blocker Edema : Dihydropyridines (such as amlodipine) relax precapillary arteriolar smooth muscle without dilating postcapillary venules. This selective precapillary vasodilation increases intracapillary hydrostatic pressure, causing transudation of fluid into the interstitial space of dependent tissues. Patients develop bilateral ankle and lower leg edema that worsens toward the end of the day. This edema is purely hydrostatic and does not reflect cardiac ventricular failure, hepatic cirrhosis, nephrotic syndrome, or Spleen/Kidney Yang deficiency. +----------------------------------------------------------------------------+
- | BETA-BLOCKER HYPOGLYCEMIA BLUNTING |
- +----------------------------------------------------------------------------+
- | Sympathetic Adrenergic Signs (BLUNTED by beta-blockers): |
- | - Tachycardia / Palpitations --> [BLOCKED] |
- | - Fine hand tremors --> [BLOCKED] |
- | - Subjective anxiety / agitation --> [BLOCKED] |
- | |
- | Sympathetic Cholinergic Signs (PRESERVED / NOT blunted): |
- | - Profuse diaphoresis (sweating) --> [INTACT CLINICAL WARNING SIGN] |
- +----------------------------------------------------------------------------+
- Anticoagulants and Antiplatelet Therapies
Anticoagulants and antiplatelet drugs inhibit the coagulation cascade or suppress platelet aggregation. These medications are ubiquitous in patients with atrial fibrillation, mechanical prosthetic heart valves, deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and coronary stenting.
Pharmaceutical Category Drug Names Laboratory Monitoring Clinical Hemorrhagic Manifestations Needle Safety & Procedural Modifications
Vitamin K Antagonists Warfarin (Coumadin) Prothrombin Time (PT) / International Normalized Ratio (INR) ; therapeutic range: 2.0–3.0 (2.5–3.5 for mechanical valves) Extensive subcutaneous ecchymoses, hematuria, epistaxis, gingival bleeding, gastrointestinal bleeding (melena), intracranial bleed INR > 3.5–4.0 contraindicates needling; use fine needles (36–40 gauge); avoid deep intramuscular insertions; avoid strong manipulation; hold manual pressure for 2–3 minutes; strictly avoid wet cupping, gua sha, plum blossom
Direct Oral Anticoagulants (DOACs: Factor Xa Inhibitors) Apixaban (Eliquis), Rivaroxaban (Xarelto), Edoxaban No routine coagulation monitoring; anti-Xa levels in special cases Spontaneous hematomas, prolonged bleeding from puncture sites, hidden retroperitoneal or joint hemorrhages (hemarthrosis) Same procedural modifications as warfarin; rapid onset and offset; avoid vigorous needle rotation; inspect insertion sites before patient discharge
Direct Thrombin Inhibitors Dabigatran (Pradaxa) Thrombin Time (TT), ecarin clotting time; no routine monitoring Gastrointestinal distress/bleeding, hematuria, extensive ecchymosis Avoid deep intramuscular needling into dense, non-compressible compartments (e.g., deep gluteal, calf)
Antiplatelet Agents Aspirin (acetylsalicylic acid), Clopidogrel (Plavix), Ticagrelor (Brilinta) Platelet function assays (rarely monitored routinely) Petechiae, purpura, easy bruising, prolonged oozing from minor skin breaks Gentle needling; use dry cotton ball compression; strictly contraindicate wet cupping and vigorous scraping / gua sha
Caution
Hematoma and Bleeding Contraindications : In any patient receiving therapeutic anticoagulation (Warfarin, DOACs) or dual antiplatelet therapy (aspirin + clopidogrel):
Deep intramuscular needling in non-compressible muscular compartments (e.g., deep points in the gastrocnemius, tibialis anterior, gluteus medius) carries a significant risk of intramuscular hematoma and acute compartment syndrome.
Wet cupping ( Ci Luo / bleeding cupping), plum blossom seven-star hammering, lancet bloodletting, and vigorous Gua Sha are absolutely contraindicated due to the danger of unprovoked hemorrhage.
After withdrawing any acupuncture needle, apply direct, firm, continuous manual pressure with a sterile dry cotton ball for a minimum of 60 to 180 seconds.
Lipid-Lowering Statins: The Musculoskeletal Mimic
Statins (HMG-CoA reductase inhibitors: atorvastatin, simvastatin, rosuvastatin, pravastatin) are prescribed to lower low-density lipoprotein cholesterol (LDL-C) and reduce cardiovascular events. Statins inhibit the conversion of HMG-CoA to mevalonate, depleting downstream metabolites including ubiquinone (coenzyme Q10 / CoQ10), which impairs mitochondrial respiration in skeletal myocytes.
Spectrum of Statin Muscle Toxicity :
Statin-Associated Muscle Symptoms (SAMS) / Myalgia : Muscle aching, soreness, stiffness, or cramping without significant enzyme elevation; occurs in 5% to 15% of treated patients.
Myositis / Myopathy : Muscle symptoms accompanied by objective muscle weakness and elevation of serum Creatine Kinase (CK) to greater than 10 times the upper limit of normal (>10x ULN).
Rhabdomyolysis : Severe, life-threatening skeletal muscle breakdown resulting in the leakage of massive quantities of intracellular contents—myoglobin, potassium, and CK—into the systemic circulation.
The Clinical Trap for Acupuncturists : Patients frequently present to an acupuncture clinic with a chief complaint of "new-onset generalized fibromyalgia," "worsening lumbar strain," or "bilateral shoulder and hip stiffness" within weeks to months of starting a statin or increasing its dosage. Misinterpreting this presentation as simple Qi and Blood stagnation or Bi syndrome delays critical biomedical intervention.
Diagnostic Red Flags for Rhabdomyolysis :
Bilateral, symmetrical proximal muscle weakness and deep muscular tenderness (affecting the quadriceps, gluteal muscles, and shoulder girdle).
Dark, reddish-brown "tea-colored" or "cola-colored" urine , indicating profound myoglobinuria .
Serum Creatine Kinase (CK) levels elevated from several thousand to >50,000 U/L.
Hyperkalemia, hyperphosphatemia, and acute kidney injury (tubular obstruction by filtered myoglobin casts).
Immediate Action : Withhold all manual therapy; instruct the patient to immediately discontinue the statin under medical direction; arrange urgent emergency department transport for aggressive intravenous fluid hydration to preserve renal function.
Anti-Angina Medications
Drug Use Key side effects and precautions
Nitroglycerin (under the tongue or spray) Relieves an angina attack within minutes by dilating veins and coronary arteries Headache, flushing, dizziness, low blood pressure; never combine with PDE5 inhibitors such as sildenafil or tadalafil (severe hypotension)
Long-acting nitrates (isosorbide mononitrate) Prevent angina Headache; same PDE5 inhibitor interaction
Beta blockers and calcium channel blockers Reduce the heart's oxygen demand See the antihypertensive table above
Ranolazine Chronic angina Dizziness, constipation, QT prolongation
If a patient with known angina has chest pain in the clinic, have them rest and take their prescribed nitroglycerin. If the pain is not improved or is worsening 5 minutes after the first dose , call 911. Chest pain in a patient without a known diagnosis needs 911 immediately.
Analgesics, Anti-inflammatories, and Corticosteroids
Patients seeking acupuncture for chronic pain frequently consume over-the-counter and prescription analgesics. These agents carry profound gastrointestinal, hepatic, renal, and skeletal toxicities. +----------------------------------------------------------------------------+
- | ANALGESIC & ANTI-INFLAMMATORY ADVERSE PROFILE |
- +----------------------------------------------------------------------------+
- | NSAIDs: GI ulceration/perforation, renal vasoconstriction |
- | Acetaminophen: NAPQI metabolite hepatotoxicity (safe max: 3-4 g/day) |
- | Corticosteroids: Osteoporosis, HPA axis collapse, skin thinning, diabetes |
- | Opioids: Fatal respiratory depression, miosis, unremitting constip|
- +----------------------------------------------------------------------------+
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Mechanisms : Non-selective NSAIDs (ibuprofen, naproxen, ketorolac, meloxicam) inhibit both Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2). Selective NSAIDs (celecoxib) selectively inhibit COX-2.
Gastrointestinal Toxicity : COX-1 produces mucosal prostaglandins (PGI2, PGE2) that stimulate gastric mucus and bicarbonate secretion while maintaining mucosal blood flow. Non-selective NSAIDs strip these protective mechanisms, causing erosive gastritis, gastric and duodenal ulcers, and life-threatening gastrointestinal hemorrhage. NSAID ulcers are notoriously "silent," presenting with painless melena (black tarry stools), hematemesis (coffee-ground emesis), or acute hemorrhagic shock.
Renal Toxicity : In states of reduced effective circulating volume, renal blood flow depends critically on vasodilatory prostaglandins (PGE2, PGI2) acting on the afferent renal arteriole . NSAIDs extinguish prostaglandin synthesis, causing afferent arteriolar constriction, decreased glomerular filtration rate (GFR), acute tubular necrosis, hyperkalemia, and secondary fluid retention that exacerbates hypertension and congestive heart failure.
Cardiovascular Hazards : All NSAIDs (except aspirin, and to a lesser extent naproxen) carry an FDA black box warning for increased risks of myocardial infarction and ischemic stroke, driven by unbalanced suppression of vasodilatory endothelial prostacyclin relative to platelet thromboxane A2.
Acetaminophen (Tylenol / APAP)
Mechanism : Acts predominantly within the central nervous system to inhibit prostaglandin synthesis and modulate cannabinoid/serotonergic pathways; possesses analgesic and antipyretic efficacy but lacks significant peripheral anti-inflammatory or antiplatelet activity .
Metabolism and Hepatotoxicity : At therapeutic doses, 90% of acetaminophen is safely conjugated in the liver via glucuronidation and sulfation. Approximately 5% to 10% is metabolized by cytochrome P450 (specifically CYP2E1 ) into a highly reactive, toxic electrophilic intermediate: N-acetyl-p-benzoquinone imine (NAPQI) . Under normal conditions, NAPQI is rapidly detoxified by covalent binding to hepatic glutathione and excreted renally.
Toxic Thresholds and Overdose : In acute overdose or chronic supra-therapeutic ingestion (>3,000 to 4,000 mg/day in healthy adults, or >2,000 mg/day in chronic alcoholics, elderly, or malnourished patients), hepatic glutathione reserves are exhausted (>70% depletion). Unconjugated NAPQI binds covalently to cysteinyl sulfhydryl groups on hepatocyte cellular proteins, causing massive centrilobular hepatic necrosis and acute liver failure.
Antidote : Intravenous or oral N-acetylcysteine (NAC) , which replenishes intracellular glutathione stores and directly conjugates NAPQI; must be administered rapidly (ideally within 8 hours of ingestion).
Systemic Corticosteroids
Systemic glucocorticoids (prednisone, methylprednisolone, dexamethasone, hydrocortisone) are powerful anti-inflammatory and immunosuppressive agents. Prolonged systemic administration (>2–3 weeks) generates profound multisystem adverse effects:
Osteoporosis and Pathological Fractures : Glucocorticoids suppress osteoblast proliferation, stimulate osteoclast longevity, inhibit intestinal calcium absorption, and stimulate renal calcium excretion. Trabecular bone is lost rapidly, creating extreme vulnerability to pathological vertebral compression fractures , rib fractures, and femoral neck fractures. Acupuncturists must strictly avoid aggressive spinal joint manipulation, heavy cupping pressure, or forceful manual pressure along the spine.
Adrenal Suppression and Addisonian Crisis : Exogenous glucocorticoids exert negative feedback on the hypothalamus (CRH) and anterior pituitary (ACTH), causing bilateral atrophy of the adrenal cortex. If the patient abruptly discontinues the corticosteroid without a structured taper, the atrophied adrenal glands cannot produce endogenous cortisol. The patient slides into an acute adrenal (Addisonian) crisis : severe refractory hypotension, vascular collapse, severe hypoglycemia, vomiting, and shock.
Integumentary and Connective Tissue Fragility : Corticosteroids inhibit fibroblastic collagen synthesis, producing extreme skin thinning ("cigarette-paper skin"), cutaneous atrophy, capillary fragility, extensive senile purpura, and severely delayed wound healing. Needling must be performed with fine-gauge needles, and retention tapes or press seeds must be removed with extreme gentleness to avoid tearing fragile epidermis.
Steroid-Induced Hyperglycemia : Stimulates hepatic gluconeogenesis and impairs peripheral glucose uptake, destabilizing diabetic control and precipitating new-onset diabetes mellitus.
Aseptic Osteonecrosis (Avascular Necrosis) : Corticosteroid use is the leading non-traumatic cause of avascular necrosis of the femoral head. Any patient on long-term prednisone who develops deep groin or anterior hip pain on weight-bearing must be evaluated immediately with pelvic MRI.
Immunosuppression and Masked Sepsis : Corticosteroids impair leukocyte migration, lymphopenia, and suppress cytokine pyrogens. Patients with severe systemic infections (e.g., septic arthritis, spinal epidural abscess) may fail to develop a robust fever or elevated white blood cell count.
Opioid Analgesics
Opioids (morphine, oxycodone, hydrocodone, fentanyl, hydromorphone, methadone, tramadol) bind to central and peripheral mu-opioid receptors to inhibit ascending nociceptive pathways:
The Lethal Overdose Triad : (1) Coma / Unresponsiveness , (2) Pinpoint Pupils (Miosis) , and (3) Severe Respiratory Depression (respiratory rate < 8–10 breaths/min, cyanosis). Immediate administration of Naloxone (Narcan) is life-saving.
Unremitting Opioid-Induced Constipation (OIC) : Patients rapidly develop pharmacological tolerance to opioid-induced sedation, nausea, and euphoria. However, patients never develop tolerance to constipation or miosis . Mu receptors in the myenteric plexus continuously inhibit gastrointestinal peristalsis and mucosal secretion, producing refractory constipation that requires bowel regimens (stimulant laxatives, peripherally acting mu-opioid receptor antagonists like methylnaltrexone).